Antibody Drug Conjugate Market: How Is the ADC Technology Platform...

added blog Botanik

2026-05-13 11:03:51

Antibody Drug Conjugate Market: How Is the ADC Technology Platform Revolutionizing Oncology Treatment?

Antibody-drug conjugate technology's clinical maturation — the sophisticated combination of tumor-targeting monoclonal antibodies linked through engineered linkers to cytotoxic payloads (auristatins, maytansinoids, camptothecin analogues, and novel warheads) delivering targeted chemotherapy to cancer cells while sparing normal tissue — has evolved from early proof-of-concept...

0 Comments 0 Shares 69 Views 0 Reviews